Our project seeks to implement of guideline-adherent aspirin prophylaxis in pregnancy, focusing on patient screening by providers and on patient adherence to clinician recommendations in an underprivileged patient population
|Effective start/end date||12/1/20 → 11/30/21|
- AMAG Pharmaceuticals, Inc (Cavens AGMT 5/18/21)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.